Gene therapy of muscular dystrophy

被引:85
作者
Chamberlain, JS [1 ]
机构
[1] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1093/hmg/11.20.2355
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Development of gene therapy for the muscular dystrophies represents a daunting challenge requiring significant advances in our knowledge of the defective genes, muscle promoters, viral vectors, immune system surveillance and methods for systemic delivery of vectors. However, tremendous progress has been made in developing improved viral vectors and avoiding immune reactions against gene transfer. This review summarizes recent progress and highlights problems that must be solved before an effective treatment is available.
引用
收藏
页码:2355 / 2362
页数:8
相关论文
共 115 条
  • [11] Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
    Chao, HJ
    Liu, YB
    Rabinowitz, J
    Li, CW
    Samulski, RJ
    Walsh, CE
    [J]. MOLECULAR THERAPY, 2000, 2 (06) : 619 - 623
  • [12] RECOVERY OF INDUCED MUTATIONS FOR X-CHROMOSOME-LINKED MUSCULAR-DYSTROPHY IN MICE
    CHAPMAN, VM
    MILLER, DR
    ARMSTRONG, D
    CASKEY, CT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (04) : 1292 - 1296
  • [13] DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle
    Chen, HH
    Mack, LM
    Choi, SY
    Ontell, M
    Kochanek, S
    Clemens, PR
    [J]. HUMAN GENE THERAPY, 1999, 10 (03) : 365 - 373
  • [14] Persistence in muscle of an adenoviral vector that lacks all viral genes
    Chen, HH
    Mack, LM
    Kelly, R
    Ontell, M
    Kochanek, S
    Clemens, PR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1645 - 1650
  • [15] Modulation of starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route
    Cho, WK
    Ebihara, S
    Nalbantoglu, J
    Gilbert, R
    Massie, B
    Holland, P
    Karpati, G
    Petrof, BJ
    [J]. HUMAN GENE THERAPY, 2000, 11 (05) : 701 - 714
  • [16] Clemens PR, 1996, GENE THER, V3, P965
  • [17] THE HOMOLOG OF THE DUCHENNE LOCUS IS DEFECTIVE IN X-LINKED MUSCULAR-DYSTROPHY OF DOGS
    COOPER, BJ
    WINAND, NJ
    STEDMAN, H
    VALENTINE, BA
    HOFFMAN, EP
    KUNKEL, LM
    SCOTT, MO
    FISCHBECK, KH
    KORNEGAY, JN
    AVERY, RJ
    WILLIAMS, JR
    SCHMICKEL, RD
    SYLVESTER, JE
    [J]. NATURE, 1988, 334 (6178) : 154 - 156
  • [18] Rescue of skeletal muscles of γ-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer
    Cordier, L
    Hack, AA
    Scott, MO
    Barton-Davis, ER
    Gao, GP
    Wilson, JM
    McNally, EM
    Sweeney, HL
    [J]. MOLECULAR THERAPY, 2000, 1 (02) : 119 - 129
  • [19] Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies
    Cordier, L
    Gao, GP
    Hack, AA
    McNally, EM
    Wilson, JM
    Chirmule, N
    Sweeney, HL
    [J]. HUMAN GENE THERAPY, 2001, 12 (02) : 205 - 215
  • [20] DP71 CAN RESTORE THE DYSTROPHIN-ASSOCIATED GLYCOPROTEIN COMPLEX IN MUSCLE BUT FAILS TO PREVENT DYSTROPHY
    COX, GA
    SUNADA, Y
    CAMPBELL, KP
    CHAMBERLAIN, JS
    [J]. NATURE GENETICS, 1994, 8 (04) : 333 - 339